Breast cancer is now the most common cancer among women. Nearly four out of ten women diagnosed with breast cancer succumbed to the disease in India in 2020, government data show. Hyderabad-based MSN ...
TOKYO, Nov 20, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that it has launched fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor "TASFYGO Tablets 35mg" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results